Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > WOW, just look at ALL THE DOCTORS HERE. LOL

<< Previous

Bullboard Posts

Next >>

Comment by WalkOverTheStrton Aug 04, 2021 11:57am

200 Views

Post# 33648428

RE:WOW, just look at ALL THE DOCTORS HERE. LOL

topadvisor1 - what a classy act you are by showing your true colors. Bottom of humanity's barrel you seem to be part of. Congrats!
Here is a link for the different between loose and lose as you seem like you need the help ;)
https://www.dictionary.com/e/loose-vs-lose/
put on ignore, enjoy the silence...

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?